|Nobilis Health Corp. - NHC.t owns and manages ambulatory and acute care facilities to deliver healthcare services. |
Nobilis owns and manages seven surgical facilities in Dallas, Houston, and Scottsdale and has contractual partnerships with six other facilities in Arizona, Oregon, Michigan, Minnesota, Tennessee and New Jersey.
|On August 14, 2015 the company released Numbers|
Nobilis Health Corp. (NYSE MKT: HLTH) (TSX: NHC) ("Nobilis" or the "Company") today announced its financial results for the three and six months ended June 30, 2015. All dollar amounts are in United States currency unless otherwise stated; percentage calculations are based on the numbers in the financial statements and may not correspond to rounded figures presented in this release.
Chris Lloyd, Nobilis Health's CEO, said, "We are excited to announce that the Company's second quarter recorded total revenues were $48.9 million with an Adjusted EBITDA1 (net of NCI) of $7.1 million. This represents a significant improvement over the corresponding period in 2014, during which the Company's total revenues were $15.1 million, with an Adjusted EBITDA1 of $0.9 million.
While the Company historically realizes between 18.0 and 19.0% of its total annual revenue in the second quarter, our second quarter revenue of $48.9 million represents 24.0% of our original 2015 revenue guidance of $205.0 million, exceeding this historical trend. Year-to-date, our total revenues of $86.0 million represent 42.0% of our 2015 guidance and indicate strong progress toward our original guidance as, historically, the Company earns upwards of 60.0% of our revenues in the second half of the year.
Second Quarter Results
Total revenues for the three months ended June 30, 2015 totaled $48.9 million, an increase of $33.8 million or 223.8%, compared to $15.1 million from the prior corresponding 2014 period.
Total cases for the three months ended June 30, 2015 were 4,780, representing an increase of 3,134 cases or 190% from the 1,646 cases in the prior corresponding 2014 period. Revenue per case increased as a product of the procedure mix moving towards surgeries with higher reimbursements. Net loss attributable to Nobilis for the three months ended June 30, 2015 was $1.6 million compared with a net income of $0.2 million from the prior corresponding 2014 period.
The increase in total revenues resulted in Nobilis having an Adjusted EBITDA1 of $7.1 million, for the three months ended June 30, 2015 compared with $0.9 million from the prior corresponding 2014 period, representing an increase of 689.0%.
Six Months Results
Total revenues for the six months ended June 30, 2015 totaled $86.0 million, an increase of $58.8 million or 216%, compared to $27.2 million from the prior corresponding 2014 period.
By using the material on this blog you agree to all the terms of this disclaimer. You agree that the use of Penny Stock Journal is at your own risk. In no event will Penny Stock Journal be liable for any direct or indirect losses caused by any information on this site or on any linked site. The materials on the site are not an offer to sell or a solicitation of an offer to buy any security, nor shall any security be offered or sold to any person, in any jurisdiction in which such offer would be unlawful under the securities laws of such jurisdiction. Penny Stock Journal makes no representations, and specifically disclaims all warranties, express, implied, or statutory, regarding the accuracy, timeliness, or completeness of any material contained in this site. Penny Stock Journal cannot be held liable for the material contained herein. The principal of Penny Stock Journal may hold a position in any of the securities profiled on the site. Penny Stock Journal will not be responsible for reporting any changes to that position. Penny Stock Journal does not make investment recommendations. High risk stock speculation can result in large financial losses and is not suitable for some investors.